Robert W. Pangia, Director at BIOGEN IDEC INC. (BIIB), sold 11,000 shares at $64.88 ($712K) on 2008-04-08, disclosed to the SEC on 2008-04-10.
Scheduled sale ($712k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.52 | 400 | $26K | 3.6% |
| 2 | $64.53 | 110 | $7K | 1.0% |
| 3 | $64.54 | 100 | $6K | 0.9% |
| 4 | $64.55 | 500 | $32K | 4.5% |
| 5 | $64.56 | 90 | $6K | 0.8% |
| 6 | $64.57 | 200 |
| $13K |
| 1.8% |
| 7 | $64.61 | 200 | $13K | 1.8% |
| 8 | $64.63 | 200 | $13K | 1.8% |
| 9 | $64.64 | 100 | $6K | 0.9% |
| 10 | $64.67 | 700 | $45K | 6.4% |
| 11 | $64.69 | 200 | $13K | 1.8% |
| 12 | $64.70 | 2,000 | $129K | 18.2% |
| 13 | $64.71 | 100 | $6K | 0.9% |
| 14 | $64.72 | 200 | $13K | 1.8% |
| 15 | $64.74 | 600 | $39K | 5.5% |
| 16 | $64.78 | 100 | $6K | 0.9% |
| 17 | $64.79 | 300 | $19K | 2.7% |
| 18 | $64.80 | 900 | $58K | 8.2% |
| 19 | $64.82 | 600 | $39K | 5.5% |
| 20 | $64.83 | 600 | $39K | 5.5% |
| 21 | $64.84 | 100 | $6K | 0.9% |
| 22 | $64.85 | 400 | $26K | 3.6% |
| 23 | $64.86 | 300 | $19K | 2.7% |
| 24 | $64.87 | 300 | $19K | 2.7% |
| 25 | $64.88 | 700 | $45K | 6.4% |
| 26 | $64.90 | 700 | $45K | 6.4% |
| 27 | $64.94 | 300 | $19K | 2.7% |
| Total | $64.75 avg | 11,000 | $712K | 100% |
| Filing → |
| BIIB | SELL | 2017-01-10 | $3.2M | — | Filing → |
| BIIB | SELL | 2015-03-11 | $1.5M | — | Filing → |
| BIIB | SELL | 2014-04-02 | $1.9M | — | Filing → |